Marine-Derived Peptides Show Potent Anticancer Activity | Promising Candidates RV1 and RV2 Enhance Breast Cancer Treatments

In this episode of SciBud, we dive into groundbreaking research that explores the potential of marine-derived peptides as new players in the fight against breast cancer. Join Rowan as we unpack a study focusing on peptides isolated from the predatory sea snail, Rapana venosa, and their promising effects on two critical breast cancer cell lines: estrogen receptor-positive MCF-7 and aggressive triple-negative MDA-MB-231. With RV1 and RV2 showing significant cytotoxic effects at lower concentrations than the commonly used chemotherapy drug doxorubicin, we discuss how these peptides induce cell cycle arrest and promote programmed cell death, offering a beacon of hope for more targeted and effective therapies. While the study highlights thrilling possibilities, it also calls for further validation of findings and data accessibility. Tune in to learn how oceanic resources might hold the key to future advancements in cancer treatment, and as always, stay curious with SciBud! Link to episode page with article citation: www.scibud.media/podcast/season/2025/episode/163